| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035497 |
| Receipt No. | R000040446 |
| Scientific Title | Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. A randomized controlled study. |
| Date of disclosure of the study information | 2019/01/19 |
| Last modified on | 2021/01/10 (Ver. 8) |
| Basic information | ||
| Public title | Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. A randomized controlled study. | |
| Acronym | Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. | |
| Scientific Title | Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. A randomized controlled study. | |
| Scientific Title:Acronym | Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. | |
| Region |
|
|
| Condition | ||||
| Condition | recuriting | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | . The aim is to assess analgesic efficacy of cervical plexus block after general anesthesia for transoral thyroidectomy. The primary concern of this study is pain score. The secondary goals are hospital stay, total analgesic consumption, and side effects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | . The aim is to assess analgesic efficacy of cervical plexus block after general anesthesia for transoral thyroidectomy. The primary concern of this study is pain score. |
| Key secondary outcomes | The secondary goals are hospital stay, total analgesic consumption, and side effects. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | First group will receive general anesthesia. (Group G) | ||
| Interventions/Control_2 | second group will receive bilateral superficial cervical plexus block with ropivacaine 0.5 % after general anesthesia (Group GB). | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled for thyroid surgeries who are ASA (physical status) I or II or III with Gland width on diagnostic imaging less than ten ml, Outline of more than forty five cm ,Papillary microcarcinoma without local or distant.
|
|||
| Key exclusion criteria | Patients unfit for general anesthesia, Previous neck surgery or recurrent goiter,A gland more than 45 mL or distant metastases,Tracheal/esophageal infiltration, hyperthyroidism, mediastinal goiter,poorly- or un-differentiated cancer,
|
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Mansoura university | ||||||
| Division name | anesthesia department | ||||||
| Zip code | 00966 | ||||||
| Address | king fahed road | ||||||
| TEL | 01225303563 | ||||||
| alaaeldeep9@hotmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Dr. | ||||||
| Division name | anesthesia department | ||||||
| Zip code | 00966 | ||||||
| Address | king fahed road | ||||||
| TEL | +2050226261 | ||||||
| Homepage URL | |||||||
| alaaeldeep9@hotmail.com | |||||||
| Sponsor | |
| Institute | Mansoura university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Dr. |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Mansoura Faculty of Medicine Institutional Research Board (MFM-IRB) |
| Address | Mansoura egypt |
| Tel | +20 109 212 7930 |
| irb.mfm@hotmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.roaic.eg.net/article.asp?issn=2356-9115;year=2019;volume=6;issue=4;spage=418;epage=423;au |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://www.roaic.eg.net/article.asp?issn=2356-9115;year=2019;volume=6;issue=4;spage=418;epage=423;au | ||||||
| Number of participants that the trial has enrolled | 40 | ||||||
| Results | after applying the exclusion criteria, forty patients were randomized into two groups in this study. The postanesthesia care unit time, pain score for eight hours postoperatively, postoperative opioid requirement, and hospital stay were statistically significantly less in the second group than in the control group. Patient satisfaction is more observed in the second group.
|
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | The postanesthesia care unit time, pain score for8hours postoperatively, postoperative opioid requirement, and hospital stay were statistically significantly less in the second group than in the control group. Patient satisfaction is more observed in the second group.
|
||||||
| Participant flow | summary results within 12 months of the date on which the final data were collected will be submitted. | ||||||
| Adverse events | no adverse effects | ||||||
| Outcome measures | The postanesthesia care unit time, pain score for8 hours postoperatively, postoperative opioid requirement, and hospital stay were statistically significantly less in the second group than in the control group. Patient satisfaction is more observed in the second group.
|
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040446 |